Canadian Online Pharmacy

CDRH Transparency Update

You are subscribed to CDRH Transparency for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

The following PMAs were recently added to Premarket Approval (PMA) Summary Review memos for 180-Day Design Changes .

P950037/S100

P000009/S047

P050023/S0478

P070008/S028

Transparency home page 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery